RFablation Ablation System

RFablation is a radiofrequency ablation platform for percutaneous thermal therapy of solid lesions under imaging guidance where clinically appropriate. The system is positioned for multidisciplinary teams in thyroid, breast, liver, lung, and other interventional programs that follow local oncology and interventional radiology guidelines.

System overview

Console & electrode family

Indications (subject to IFU and local registration)

• Thyroid and breast nodule management where thermal ablation is clinically indicated.
• Liver and lung lesion workflows under appropriate imaging guidance.
• Uterine and prostate-related interventional programs per institutional protocols.
• Other solid-tumor thermal therapy scenarios per specialist judgment and national guidance.

Core technology themes

• Controlled RF delivery for predictable coagulation zones in targeted tissue.
• Impedance-aware monitoring concepts to support stable energy application during treatment.
• Constant-power strategies aligned with lesion size and tissue type (per IFU tables).
• Integration with ultrasound and other imaging workflows for needle placement and monitoring.
• Design emphasis on char reduction and smoke burden in suitable generator modes.

Constant power & coagulation control

During ablation, delivered power should remain within a therapeutic window: high enough to achieve coagulation of the intended lesion, yet controlled to limit collateral thermal injury. RFablation systems typically target stable output within the operating impedance range so that each activation produces a predictable ablation footprint when protocol and needle selection are followed.

Tissue response & impedance

Impedance-based feedback helps the operator judge tissue changes during RF delivery. Products that use temperature or impedance as primary endpoints should be used strictly according to validated parameters for your registration.

Safety & effectiveness (positioning summary)

Targeting. Superficial lesions in organs such as the breast allow ultrasound visualization of the electrode path for placement confidence.

Access. Percutaneous entry minimizes surgical exposure when the clinical plan supports an interventional route.

Monitoring. System impedance pathways and power caps can reduce the risk of uncontrolled extension beyond the intended volume when limits are respected.

Energy source. RF thermal effects are intended to achieve cell death in the target zone while sparing adjacent structures when anatomy and parameters are appropriate.

Minimally invasive profile

• Small skin entry and needle-based access route.
• Electrode diameters in common clinical ranges (exact sizes per catalog / IFU).
• RF energy delivery without ionizing radiation from the generator itself; imaging modalities follow department protocols.

Typical configuration

• RF ablation generator with impedance monitoring and power control.
• Ablation needle set - multiple lengths and gauges for lesion depth and shape.
• Ultrasound-guided procedure accessories as cleared in your market.

Disclaimer

Interventional ablation requires qualified specialists, multidisciplinary indications review, and informed consent. Indications, contraindications, and labeling differ by country. This English summary supports marketing; the IFU and regulatory certificate for your territory prevail.